01793oam 2200457 450 991071351480332120220415144832.029-412(CKB)5470000002502519(OCoLC)1156626967(OCoLC)995470000002502519(EXLCZ)99547000000250251920200603d2020 ua 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierPerspectives on the 340B Drug Pricing Program hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining perspectives on the 340B drug discount program, March 15, 2018Washington :U.S. Government Publishing Office,2020.1 online resource (iii, 70 pages)S. hrg. ;115-810Access ID (govinfo): CHRG-115shrg29412.Includes bibliographical references.Perspectives on the 340B Drug Pricing Program Prescription pricingGovernment policyUnited StatesDrugsPricesGovernment policyUnited StatesPoorPharmaceutical assistanceUnited StatesOlder peoplePharmaceutical assistanceUnited StatesLegislative hearings.lcgftPrescription pricingGovernment policyDrugsPricesGovernment policyPoorPharmaceutical assistanceOlder peoplePharmaceutical assistanceGPOGPOGPOBOOK9910713514803321Perspectives on the 340B Drug Pricing Program3474770UNINA